Clinical Trial Update: RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating RiaSTAP versus conventional transfusion in patients undergoing heart valve surgery was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Valvular Heart Disease

Drugs mentioned

• RiaStap

Snippet

Sponsor: Emory University | Conditions: Heart Valve Disease, Coronary Artery Disease | Phase 2 | Status: TERMINATED | Results posted: 2015-02-16